SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-192777
Filing Date
2004-11-10
Accepted
2004-11-10 15:54:16
Documents
9
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 d10q.htm 10-Q 421457
2 COLLABORATION AND LICENSE AGREEMENT dex101.htm EX-10.1 216675
3 COLLABORATION AGREEMENT dex102.htm EX-10.2 273519
4 AMENDMENT NO. 2 TO COLLABORATION AGREEMENT dex103.htm EX-10.3 15025
5 AMENDMENT NO. 3 TO LICENSE AGREEMENT dex104.htm EX-10.4 13304
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8687
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8532
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3570
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3490
  Complete submission text file 0001193125-04-192777.txt   966885
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32405 | Film No.: 041133178
SIC: 2836 Biological Products, (No Diagnostic Substances)